1. Home
  2. SSTK vs OCGN Comparison

SSTK vs OCGN Comparison

Compare SSTK & OCGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shutterstock Inc.

SSTK

Shutterstock Inc.

HOLD

Current Price

$5.80

Market Cap

570.9M

Sector

Technology

ML Signal

HOLD

Logo Ocugen Inc.

OCGN

Ocugen Inc.

N/A

Current Price

$1.35

Market Cap

474.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SSTK
OCGN
Founded
2003
2013
Country
United States
United States
Employees
N/A
116
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
570.9M
474.8M
IPO Year
2012
2014

Fundamental Metrics

Financial Performance
Metric
SSTK
OCGN
Price
$5.80
$1.35
Analyst Decision
Buy
Strong Buy
Analyst Count
2
4
Target Price
$25.00
$9.75
AVG Volume (30 Days)
1.3M
4.4M
Earning Date
04-28-2026
05-05-2026
Dividend Yield
8.61%
N/A
EPS Growth
23.76
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$4.35
N/A
Revenue Next Year
N/A
$1,718.38
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.17
$0.98
52 Week High
$29.50
$2.73

Technical Indicators

Market Signals
Indicator
SSTK
OCGN
Relative Strength Index (RSI) 34.12 52.17
Support Level $5.17 $1.30
Resistance Level $6.65 $1.58
Average True Range (ATR) 0.50 0.07
MACD 0.23 0.02
Stochastic Oscillator 41.13 66.67

Price Performance

Historical Comparison
SSTK
OCGN

About SSTK Shutterstock Inc.

Shutterstock Inc is a U.S.-based company that is engaged in the provision of digital content. The content segment, whose offerings include licenses for Images, Footage, Music, 3 Dimensional, and Generative AI content. Data, Distribution, and Service offerings address customer demand for products and services that are beyond its Content licenses. The company generates the majority of its revenue from Content offerings. Geographically the company generates the majority of its revenue from the Domestic market, but also has its presence in Europe and Rest of the Countries.

About OCGN Ocugen Inc.

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

Share on Social Networks: